Trials / Completed
CompletedNCT01783834
Gefitinib Versus Pemetrexed for Previously Treated NSCLC Patients
Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients With Advanced Non-small Cell Lung Cancer
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 95 (actual)
- Sponsor
- Gachon University Gil Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To compare the efficacy of gefitinib versus pemetrexed as second-line chemotherapy for patients with previous treated non-small cell lung cancer
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Gefitinib | compare progression free survivla rate and safety to both drugs |
| DRUG | Pemetrexed | compare PFS rate, safety to both drugs |
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2014-06-01
- Completion
- 2014-06-01
- First posted
- 2013-02-05
- Last updated
- 2016-02-11
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01783834. Inclusion in this directory is not an endorsement.